Literature DB >> 16533208

Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia.

Hsu-Tang Liu1, Shen-Kou Tsai, Ming-Chang Kao, Jenkin S Hu.   

Abstract

Botulinum toxin type A (BTX-A) has been widely used in many clinical disorders including migraine, cervical dystonia, etc. The use of BTX-A in neuropathic pain, however, is uncommon, and the application of the anti-nociceptive effect of botulinum toxin is emerging. Here we report a case of an 80-year-old man who suffered from severe pain of post-herpetic neuralgia which was refractory to the usual therapies. However, this neuropathic pain was dramatically relieved by multiple BTX-A injection and the pain relief lasted 52 days.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533208     DOI: 10.1111/j.1526-4637.2006.00100.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  14 in total

Review 1.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

Review 2.  [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].

Authors:  L Halb; B J Amann; H Bornemann-Cimenti
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

3.  Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.

Authors:  Marc J Marino; Tetsuji Terashima; Joanne J Steinauer; Kelly A Eddinger; Tony L Yaksh; Qinghao Xu
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

Review 4.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

5.  Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.

Authors:  Roshni Ramachandran; Carmen Lam; Tony L Yaksh
Journal:  Neurobiol Dis       Date:  2015-05-06       Impact factor: 5.996

6.  The efficacy of intradermal injection of botulinum toxin in patients with post-herpetic neuralgia.

Authors:  M R Emad; M Emad; P Taheri
Journal:  Iran Red Crescent Med J       Date:  2011-05-01       Impact factor: 0.611

Review 7.  Botulinum Toxin for Neuropathic Pain: A Review of the Literature.

Authors:  Hyun-Mi Oh; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-08-14       Impact factor: 4.546

Review 8.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

9.  Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.

Authors:  Zee-A Han; Dae Heon Song; Hyun-Mi Oh; Myung Eun Chung
Journal:  Ann Neurol       Date:  2016-02-16       Impact factor: 10.422

10.  Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report.

Authors:  Kyung Eun Nam; Joon Sung Kim; Bo Young Hong; Bomi Sul; Hyehoon Choi; So Yeon Jun; Seong Hoon Lim
Journal:  Ann Rehabil Med       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.